Both Gd-NTs and Mb@NTs enhanced the therapeutic efficacy of RT, as the tumor growth of these two groups was delayed (Fig. 4b, c), and the overall survival was improved (Fig. 4d). The gene discussed is MB; the disease is neoplasm.